Gapping up
In reaction to strong earnings/guidance: MOBI +16.2%, LCI +5.5%.
M&A news: DG +8.9% (Dollar General (DG) offers to acquire FDO for $78.50/share in cash), FDO +4.6% (Dollar General (DG) offers to acquire FDO for $78.50/share in cash), YHOO +1.1% (acquired ClarityRay).
Select China related names showing strength: CHL +3.1%, JD +2.1%, DANG +1.8%.
Select pharma/biotech stocks trading higher: AZN +2.1%, GILD +2%, CELG +1.3%.
Select names showing strength following positive Barron's mention: SLB +1.8%, COP +1.3%, GCI +0.7%.
Other news: JRJC +4.7% (announced that it has launched China's first independent web-based securities trading platform), TASR +4.6% (demand increasing for its cameras following Ferguson incident, according to NYPost), JBLU +3.4% (still checking), GTAT +3.1% (still checking), KNDI +2.7% (reports of EV production increase in China), HLSS +0.9% (announces filing of restated financial statements; no impact to retained earnings for 2Q14), BITA +0.9% (announces joint venture with Yong Da Group and UXIN ), TSLA +0.8% (announces its 85 kWh Model S now has an 8 year, infinite mile warranty on both the battery pack and the drive unit), BIIB +0.7% (PLEGRIDY approved in the US for the treatment of multiple sclerosis), LOGI +0.7% (granted Nasdaq extension for compliance with listing rule).
Analyst comments: ACHN +7.4% (upgraded to Buy from Hold at Deutsche Bank), TKMR +6.1% (initiated with a Outperform at Leerink Partners), HK +2.7% (upgraded to Buy from Hold at MLV & Co), ARMH +1.9% (added to Conviction Buy list at Goldman), SEAS +1.8% (initiated with a Outperform at Credit Suisse), XENT +1.3% (initiated with a Overweight at Piper Jaffray), HPQ +0.9% (upgraded to Buy at Monness Crespi & Hardt), GE +0.7% (reinstated with an Outperform at Credit Suisse), AAPL +0.6% (positive comments from RBC, also pos mention in Barrons)
In reaction to strong earnings/guidance: MOBI +16.2%, LCI +5.5%.
M&A news: DG +8.9% (Dollar General (DG) offers to acquire FDO for $78.50/share in cash), FDO +4.6% (Dollar General (DG) offers to acquire FDO for $78.50/share in cash), YHOO +1.1% (acquired ClarityRay).
Select China related names showing strength: CHL +3.1%, JD +2.1%, DANG +1.8%.
Select pharma/biotech stocks trading higher: AZN +2.1%, GILD +2%, CELG +1.3%.
Select names showing strength following positive Barron's mention: SLB +1.8%, COP +1.3%, GCI +0.7%.
Other news: JRJC +4.7% (announced that it has launched China's first independent web-based securities trading platform), TASR +4.6% (demand increasing for its cameras following Ferguson incident, according to NYPost), JBLU +3.4% (still checking), GTAT +3.1% (still checking), KNDI +2.7% (reports of EV production increase in China), HLSS +0.9% (announces filing of restated financial statements; no impact to retained earnings for 2Q14), BITA +0.9% (announces joint venture with Yong Da Group and UXIN ), TSLA +0.8% (announces its 85 kWh Model S now has an 8 year, infinite mile warranty on both the battery pack and the drive unit), BIIB +0.7% (PLEGRIDY approved in the US for the treatment of multiple sclerosis), LOGI +0.7% (granted Nasdaq extension for compliance with listing rule).
Analyst comments: ACHN +7.4% (upgraded to Buy from Hold at Deutsche Bank), TKMR +6.1% (initiated with a Outperform at Leerink Partners), HK +2.7% (upgraded to Buy from Hold at MLV & Co), ARMH +1.9% (added to Conviction Buy list at Goldman), SEAS +1.8% (initiated with a Outperform at Credit Suisse), XENT +1.3% (initiated with a Overweight at Piper Jaffray), HPQ +0.9% (upgraded to Buy at Monness Crespi & Hardt), GE +0.7% (reinstated with an Outperform at Credit Suisse), AAPL +0.6% (positive comments from RBC, also pos mention in Barrons)